Stock Analiz

Zimmer Biomet Holdings, Inc. (ZBH) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026

Summary

Zimmer Biomet’s revenue went from $7.7B in fiscal 2016 to $8.2B in fiscal 2025, growth of about 0.8% a year.

Net income in fiscal 2025 was $705M, a net margin of 8.6%; the best year in this period was 2017 with $1.8B.

Over the twelve months to September 30, 2026, revenue was $8.6B and net income $767M.

Free cash flow was $1.5B in fiscal 2025 and positive in 10 of the 10 years shown.

Revenue, profit and cash flow by year

Revenue
2016: $7.7B162017: $7.8B172018: $7.9B182019: $8.0B192020: $6.1B202021: $6.8B212022: $6.9B222023: $7.4B232024: $7.7B242025: $8.2B25$8.2B
Net income
2016: $306M162017: $1.8B172018: -$379M182019: $1.1B192020: -$139M202021: $402M212022: $231M222023: $1.0B232024: $904M242025: $705M25$705M
Free cash flow
2016: $1.4B162017: $1.4B172018: $1.6B182019: $1.4B192020: $1.1B202021: $1.4B212022: $1.2B222023: $1.3B232024: $1.3B242025: $1.5B25$1.5B
EPS (diluted)
2016: $1.51162017: $8.90172018: $-1.86182019: $5.47192020: $-0.67202021: $1.91212022: $1.10222023: $4.88232024: $4.43242025: $3.5525$3.55

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$8.6B$8.2B$7.7B$7.4B$6.9B$6.8B$6.1B$8.0B$7.9B$7.8B$7.7B
Gross profit$6.0B$5.7B$5.5B$5.3B$4.9B$4.9B$4.3B$5.7B$5.7B$5.7B$5.3B
Operating income$1.2B$1.1B$1.3B$1.3B$696M$860M$83M$1.1B$34M$799M$821M
Net income$767M$705M$904M$1.0B$231M$402M-$139M$1.1B-$379M$1.8B$306M
EPS (diluted)$3.96$3.55$4.43$4.88$1.10$1.91$-0.67$5.47$-1.86$8.90$1.51
R&D$433M$458M$437M$459M$406M$436M$323M$449M$392M$370M$366M
Revenue growth—+7.2%+3.9%+6.6%+1.7%+11.4%−23.2%+0.6%+1.7%+1.8%+27.9%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$1.9B$1.7B$1.5B$1.6B$1.4B$1.5B$1.2B$1.6B$1.7B$1.6B$1.6B
Capital spending-$241M-$224M-$204M-$291M-$188M-$144M-$112M-$207M-$163M-$156M-$185M
Free cash flow$1.6B$1.5B$1.3B$1.3B$1.2B$1.4B$1.1B$1.4B$1.6B$1.4B$1.4B
Dividends paid$187M$190M$196M$201M$201M$200M$198M$197M$195M$194M$188M
Buybacks$829M$487M$868M$692M$126M—————$416M
Stock-based pay$97M$90M$101M$100M$105M$76M$74M$84M$66M$54M$57M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$592M$526M$416M$376M$378M$802M$618M$543M$524M$634M
Debt—$7.8B$6.4B$6.0B$5.9B$7.4B$8.4B$8.5B$9.2B$10.1B$11.2B
Equity—$12.7B$12.5B$12.5B$12.0B$12.7B$12.2B$12.4B$11.3B$11.7B$9.7B
Total assets—$23.1B$21.4B$21.5B$21.1B$23.5B$24.4B$24.6B$24.1B$26.0B$26.7B
Shares (diluted)191M199M204M210M210M210M207M207M204M204M202M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin69.7%69.7%71.5%71.8%70.9%71.3%70.2%71.8%71.4%72.7%68.9%
Operating margin13.6%13.3%16.7%17.3%10.0%12.6%1.4%14.2%0.4%10.2%10.7%
Net margin9.0%8.6%11.8%13.9%3.3%5.9%-2.3%14.2%-4.8%23.2%4.0%
FCF margin19.2%17.9%16.9%17.4%16.8%19.9%17.8%17.3%20.0%18.3%18.9%
ROIC—4.6%5.9%6.6%2.8%3.8%0.3%4.3%0.1%2.9%3.0%
ROE—5.5%7.2%8.2%1.9%3.2%-1.1%9.1%-3.4%15.5%3.2%

Frequently asked questions

What is Zimmer Biomet’s annual revenue?

$8.2B in fiscal 2025 and $8.6B over the twelve months to September 30, 2026.

How much profit does Zimmer Biomet make?

Net income was $705M in fiscal 2025 (net margin 8.6%).

Is Zimmer Biomet’s revenue growing?

Yes: revenue rose 7.2% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.